A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
CONCLUSIONS: This review summarizes the literature regarding the antineoplastic mechanisms, clinical implications, and future trajectory of clinical research for metformin in prostate cancer.
PMID: 27836248 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Hankinson SJ, Fam M, Patel NN Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Epidemiology | External Beam Therapy | Fortamet | Insulin | Metabolic Syndrome | Metformin | Obesity | Prostate Cancer | Radiation Therapy | Science | Study | Urology & Nephrology
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024